chapter transform unfold
innov drive chang treatment landscap
expect temper acceler invest
asset sale quantif modest posit callon fight vs
analyst certif import disclosur see
chapter transform unfold
wed sep attend outperform-r best buy analyst investor day host nyse
servic healthcar remain top prioriti compani newli announc push toward sale
period end jan overal left construct view given collect top-linedriv initi play
addit opportun elimin product cost layer expens view discount share valuat
mani way evolut todaya highli effect omnichannel oper expand new
consum verticalsserv roadmap other look break mold tradit brick mortar retail said
believ investor still fulli embrac improv sale earn potenti revamp model
innov drive chang treatment landscap
fall opco investor summit host kol panel dr jonathan field discuss evolv treatment
paradigm past present futur hereditari angioedema despit grow character orphan
diseas sinc cinryz regulatori approv treatment paradigm evolv avail access
acut therapi new mechan action mode deliveri discuss walk away renew
interest potenti altern modal oral therapi also view current market dynam
remain fragment due spectrum diseas sever extent ripe disrupt compani
interest discuss includ shire takeda pharm biocryst attun pharvari ioni adverum
highlight takeaway
expect temper acceler invest
factset report rel stabl oper result asv grew year/year organ organ revenu
grew adjust ep grew vs our/street estim includ benefit lower
expect tax rate adj oper margin expand y/i easili exceed estim
provid soft disappoint guidanc consensu midpoint appar temper first tranch
acceler invest next three year unclear degre offset growth benefit await
commentari confer call howev anticip signific share weak maintain perform rate estim
review
asset sale quantif modest posit callon fight vs activist
view morn updat modest posit sharehold callon continu make case carrizo
acquisit face vocal activist investor come deal file morn callon quantifi
asset sale paramet hope achiev close carrizo acquisit compani announc plan
execut asset sale year-end asset sale option mention surpris non-cor
non-oper acreag eagl ford permian basin jv/sale callon water infrastructur
surpris scale sale meaning reduc debt leverag although unclear much product
would includ sale current model base show year-end leverag
year-end debt expect signific share price reaction news believ updat
may prompt respons activist favor acquisit
deliv solid finish adjust ep vs exceed expect total
revenue/adjust ebitda increas y/i respect total leas revenu grew y/i north america leas
revenu increas y/i expans construction/commercial/retail sector partli off-set decreas oil ga
sector asia pacif leas revenu flat y/i y/i local currenc north america/asia pacif adjust ebitda grew
y/i reduc estim approxim midpoint introduc revenue/adjust
ebitda guidanc y/i trade ev/ebitda
adjust ebitda vs histor averag oil ga sector conditions/techn pattern like dictat
